AXCELIS TECHNOLOGIES INC (ACLS) Fundamental Analysis & Valuation

NASDAQ:ACLS • US0545402085

86.62 USD
+0.74 (+0.86%)
At close: Mar 4, 2026
86.23 USD
-0.39 (-0.45%)
After Hours: 3/4/2026, 8:07:20 PM

This ACLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, ACLS scores 6 out of 10 in our fundamental rating. ACLS was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACLS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. ACLS Profitability Analysis

1.1 Basic Checks

  • ACLS had positive earnings in the past year.
  • ACLS had a positive operating cash flow in the past year.
  • In the past 5 years ACLS has always been profitable.
  • Each year in the past 5 years ACLS had a positive operating cash flow.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

  • ACLS has a better Return On Assets (8.83%) than 79.13% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.62%, ACLS is in the better half of the industry, outperforming 75.65% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.93%, ACLS is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
  • ACLS had an Average Return On Invested Capital over the past 3 years of 16.09%. This is significantly above the industry average of 10.50%.
  • The 3 year average ROIC (16.09%) for ACLS is well above the current ROIC(8.93%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROIC 8.93%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • ACLS's Profit Margin of 14.33% is fine compared to the rest of the industry. ACLS outperforms 73.04% of its industry peers.
  • In the last couple of years the Profit Margin of ACLS has grown nicely.
  • Looking at the Operating Margin, with a value of 14.22%, ACLS is in the better half of the industry, outperforming 71.30% of the companies in the same industry.
  • ACLS's Operating Margin has improved in the last couple of years.
  • ACLS has a Gross Margin of 44.91%. This is comparable to the rest of the industry: ACLS outperforms 52.17% of its industry peers.
  • In the last couple of years the Gross Margin of ACLS has remained more or less at the same level.
Industry RankSector Rank
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

9

2. ACLS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ACLS is still creating some value.
  • ACLS has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ACLS has less shares outstanding
  • The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • ACLS has an Altman-Z score of 6.96. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.96, ACLS is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
  • ACLS has a debt to FCF ratio of 0.40. This is a very positive value and a sign of high solvency as it would only need 0.40 years to pay back of all of its debts.
  • ACLS has a better Debt to FCF ratio (0.40) than 80.87% of its industry peers.
  • ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • ACLS's Debt to Equity ratio of 0.04 is fine compared to the rest of the industry. ACLS outperforms 61.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Altman-Z 6.96
ROIC/WACC0.8
WACC11.1%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ACLS has a Current Ratio of 4.77. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
  • ACLS has a Current ratio of 4.77. This is in the better half of the industry: ACLS outperforms 72.17% of its industry peers.
  • ACLS has a Quick Ratio of 3.11. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ACLS (3.11) is better than 63.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.77
Quick Ratio 3.11
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. ACLS Growth Analysis

3.1 Past

  • The earnings per share for ACLS have decreased strongly by -20.81% in the last year.
  • ACLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.06% yearly.
  • Looking at the last year, ACLS shows a very negative growth in Revenue. The Revenue has decreased by -17.57% in the last year.
  • The Revenue has been growing by 12.07% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.56% on average over the next years.
  • Based on estimates for the next years, ACLS will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y-5.74%
EPS Next 2Y-1.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.42%
Revenue Next 2Y4.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. ACLS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.79, the valuation of ACLS can be described as rather expensive.
  • ACLS's Price/Earnings ratio is rather cheap when compared to the industry. ACLS is cheaper than 93.04% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ACLS to the average of the S&P500 Index (27.03), we can say ACLS is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 18.87 indicates a rather expensive valuation of ACLS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 86.96% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, ACLS is valued a bit cheaper.
Industry RankSector Rank
PE 17.79
Fwd PE 18.87
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaply inside the industry as 85.22% of the companies are valued more expensively.
  • ACLS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACLS is cheaper than 87.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.85
EV/EBITDA 15.33
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The excellent profitability rating of ACLS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.61
EPS Next 2Y-1.56%
EPS Next 3YN/A

0

5. ACLS Dividend Analysis

5.1 Amount

  • ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACLS Fundamentals: All Metrics, Ratios and Statistics

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (3/4/2026, 8:07:20 PM)

After market: 86.23 -0.39 (-0.45%)

86.62

+0.74 (+0.86%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners104.51%
Inst Owner Change3.4%
Ins Owners0.56%
Ins Owner Change-0.42%
Market Cap2.66B
Revenue(TTM)839.05M
Net Income(TTM)120.24M
Analysts72.31
Price Target107.25 (23.82%)
Short Float %16.46%
Short Ratio6.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.43%
Min EPS beat(2)18.27%
Max EPS beat(2)30.58%
EPS beat(4)4
Avg EPS beat(4)66.14%
Min EPS beat(4)18.27%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)40.33%
EPS beat(12)12
Avg EPS beat(12)31.33%
EPS beat(16)16
Avg EPS beat(16)28.84%
Revenue beat(2)2
Avg Revenue beat(2)6.67%
Min Revenue beat(2)4.69%
Max Revenue beat(2)8.66%
Revenue beat(4)4
Avg Revenue beat(4)4.62%
Min Revenue beat(4)2.12%
Max Revenue beat(4)8.66%
Revenue beat(8)7
Avg Revenue beat(8)2.58%
Revenue beat(12)11
Avg Revenue beat(12)2.76%
Revenue beat(16)15
Avg Revenue beat(16)2.72%
PT rev (1m)-1.21%
PT rev (3m)0.36%
EPS NQ rev (1m)-31.58%
EPS NQ rev (3m)-32.49%
EPS NY rev (1m)0%
EPS NY rev (3m)7.27%
Revenue NQ rev (1m)-6.96%
Revenue NQ rev (3m)-7.29%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)4.54%
Valuation
Industry RankSector Rank
PE 17.79
Fwd PE 18.87
P/S 3.17
P/FCF 24.85
P/OCF 22.48
P/B 2.57
P/tB 2.57
EV/EBITDA 15.33
EPS(TTM)4.87
EY5.62%
EPS(NY)4.59
Fwd EY5.3%
FCF(TTM)3.49
FCFY4.02%
OCF(TTM)3.85
OCFY4.45%
SpS27.33
BVpS33.7
TBVpS33.7
PEG (NY)N/A
PEG (5Y)0.61
Graham Number60.77
Profitability
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROCE 10.25%
ROIC 8.93%
ROICexc 13.17%
ROICexgc 13.17%
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
FCFM 12.75%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ROICexc(3y)30.86%
ROICexc(5y)36.82%
ROICexgc(3y)30.86%
ROICexgc(5y)36.82%
ROCE(3y)18.46%
ROCE(5y)20.85%
ROICexgc growth 3Y-38.1%
ROICexgc growth 5Y-2.58%
ROICexc growth 3Y-38.1%
ROICexc growth 5Y-2.58%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Debt/EBITDA 0.3
Cap/Depr 64.13%
Cap/Sales 1.35%
Interest Coverage 250
Cash Conversion 86.4%
Profit Quality 89%
Current Ratio 4.77
Quick Ratio 3.11
Altman-Z 6.96
F-Score5
WACC11.1%
ROIC/WACC0.8
Cap/Depr(3y)99.74%
Cap/Depr(5y)94.41%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.37%
Profit Quality(3y)69.44%
Profit Quality(5y)92.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
EPS Next Y-5.74%
EPS Next 2Y-1.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%
Revenue Next Year6.42%
Revenue Next 2Y4.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.57%
EBIT growth 3Y-17.49%
EBIT growth 5Y15.52%
EBIT Next Year-9.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.81%
FCF growth 3Y-19.47%
FCF growth 5Y11.43%
OCF growth 1Y-15.99%
OCF growth 3Y-18.13%
OCF growth 5Y11.16%

AXCELIS TECHNOLOGIES INC / ACLS FAQ

Can you provide the ChartMill fundamental rating for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACLS.


Can you provide the valuation status for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 6 / 10 to AXCELIS TECHNOLOGIES INC (ACLS). This can be considered as Fairly Valued.


What is the profitability of ACLS stock?

AXCELIS TECHNOLOGIES INC (ACLS) has a profitability rating of 8 / 10.


What is the valuation of AXCELIS TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 17.79 and the Price/Book (PB) ratio is 2.57.


What is the earnings growth outlook for AXCELIS TECHNOLOGIES INC?

The Earnings per Share (EPS) of AXCELIS TECHNOLOGIES INC (ACLS) is expected to decline by -5.74% in the next year.